Table 2 Summary of patients’ information from TCGA GBM database
TCGA GBM Database n = 151 | |||
|---|---|---|---|
P2RY12 |  | High (n = 21) | Low (n = 130) |
mRNA level ± S.D | (RNA Seq V2 RSEM) | 3263 ± 722.6 | 499.5 ± 580.1 |
Age (year) ± S.D |  | 55.1 ± 15.1 | 61.5 ± 12.4 |
Gender | Male | 17(21) | 79(130) |
Female | 4(21) | 51(130) | |
IDH1 mutation | WT | 17(21) | 127(130) |
Mutant | 4(21) | 3(130) | |
Subtype | Neural | 7(21) | 19(130) |
Pro-Neural | 1(21) | 27(130) | |
Classical | 4(21) | 35(130) | |
Mesenchymal | 5(21) | 44(130) | |
G-CIMP | 4(21) | 4(130) | |
N/A | 0 | 1(130) | |
Therapy | TMZ Chemoradiation, TMZ Chemo | 9(21) | 55(130) |
| Â | Standard Radiation, TMZ Chemo | 3(21) | 21(130) |
| Â | Nonstandard Radiation, TMZ Chemo | 2(21) | 11(130) |
| Â | Standard Radiation, Alkylating Chemo | 1(21) | Â |
| Â | Unspecified Radiation | 6(21) | 17(130) |
| Â | Alkylating Chemo | Â | 1(130) |
| Â | Standard Radiation | Â | 12(130) |
| Â | Standard Radiation, Alkylating Chemo | 3(130) | |
| Â | TMZ Chemo | 1(130) | |
| Â | Nonstandard Radiation | 4(130) | |
| Â | Unspecified Therapy | 5(130) | |